Zensor

Belfast, Northern Ireland-based Intelesens has received FDA 510(k) clearance for its wearable vital signs monitor, called zensor, designed for monitoring patients outside the hospital.

Intelesens's Zensor device.

The finalists have been announced for the Qualcomm Tricorder X Prize, lowering the field from 22 companies that had not yet dropped out to just 10 that will compete for the $10 million prize in a series of hands-on trials of their handheld, smartphone-connected diagnostic devices designed for consumer use.